Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Opos
AddedFeb 18, 2024
UpdatedJun 18, 2026
Opos

Opos

Angel

OPOS: Streamlined, compliant opioid treatment provider, reducing risk and overhead costs.

HQ
San Mateo, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded in San Mateo, California, OPOS is dedicated to providing streamlined and compliant opioid treatment solutions. Their core mission is to offer effective pain care without boundaries while ensuring regulatory compliance. OPOS focuses on reducing administrative overhead and prescribing risks, thereby generating revenue and improving operational efficiency for healthcare providers. Their services are designed to support both patients and medical professionals in managing opioid treatments safely and effectively.

Notable affiliated individuals include key members of the leadership team who bring extensive experience in healthcare and regulatory compliance. OPOS has attracted attention from investors interested in innovative healthcare solutions. The company has achieved significant milestones in reducing administrative burdens and improving patient outcomes, making a substantial impact on the opioid treatment landscape. Their commitment to compliance and efficiency has positioned them as a valuable partner in the healthcare industry.

Opos - Similar Companies

OpiSafe logo

OpiSafe

opisafe.com

OPiO logo

OPiO

opioconnect.com

Opiaid logo

Opiaid

opiaid.tech

Ophelia logo

Ophelia

ophelia.com

Opioid Clinical Management logo

Opioid Clinical Management

opioidcm.com

Recover Together logo

Recover Together

Opegi Holdings logo

Opegi Holdings

Boulder Care logo

Boulder Care

boulder.care

Sure Med Compliance logo

Sure Med Compliance

Recovery Platform logo

Recovery Platform

Continuous Precision Medicine logo

Continuous Precision Medicine

cpmed.io

American Treatment Network logo

American Treatment Network

OkCopay logo

OkCopay

Sonara Health logo

Sonara Health

sonarahealth.com

Bicycle Health logo

Bicycle Health

bicyclehealth.com

Opos - Quick Facts

Who are Opos' competitors?

Companies similar to Opos include OpiSafe, OPiO, Opiaid and Ophelia.

When was Opos founded?

Opos was founded in 2017.

Where is Opos' headquarters located?

Opos' headquarters is located in San Mateo, CA, US.

When was Opos' last funding round?

Opos' most recent funding round was for $247.6k (USD) in November 2021.

How much has Opos raised to-date?

As of Nov 26, 2021, Opos has raised a total of $247.6k (USD).

How many employees does Opos have?

Opos has 30 employees as of Feb 4, 2024.

Opos - Classification

Technology
  • Telemedicine
Geographic Exposure
  • United States
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Opioid Treatment
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 4 more industry codes
NAICS
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
SIC
  • 8060Hospitals